Abbott, Sanofi-Aventis (NYSE:SNY), and Johnson & Johnson all seem to be attracted to Bausch & Lomb, the eye-care firm that Warburg Pincus wants to divest, according to knowledgeable source. Working with Goldman Sachs, Warburg is providing interested parties access to its financial data, and seeking first-round offers by the end of January, said the sources, who added that Warburg wants a minimum of $10 billion for the division.